Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population

Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population

Dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is the rate-limiting enzyme in 5-fluorouracil (5-FU) degradation. In Caucasians, four DPYD risk variants are recognized to be responsible for interindividual variations in the development of 5-FU toxicity. However, these risk variants...

Полное описание

Библиографические подробности
Главные авторы: Eiji Hishinuma, Yoko Narita, Kai Obuchi, Akiko Ueda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Masamitsu Maekawa, Nariyasu Mano, Noriyasu Hirasawa, Masahiro Hiratsuka
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2022-06-01
Серии:Frontiers in Pharmacology
Предметы:
dihydropyrimidine dehydrogenase (DPD)
DPYD
5-fluorouracil
pharmacogenomics
genetic polymorphism
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fphar.2022.930470/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.930470/full

Схожие документы